Studies indicate that the oral form maintains the primary therapeutic benefits of injectable semaglutide in T2D patients, namely glycemic control and weight loss
On the other hand, thyroid medications, like levothyroxine and liothyronine, are used to treat thyroid disorders such as hypothyroidism and hyperthyroidism
This is because the subcutaneous injection bypasses the gastrointestinal tract during absorption
Effects of the usage of l-cysteine (l-Cys) on human health
However, the therapeutic use of the native peptide is restricted by its short plasma half-life
Nausea, Tolerance, and Individual Variation in Semaglutide Response About 2535% of patients report mild to moderate nausea during the first 48 weeks of semaglutide therapy, regardless of what they eat